PT850068E - Extracto lipidico com actividade anti-inflamatoria - Google Patents

Extracto lipidico com actividade anti-inflamatoria

Info

Publication number
PT850068E
PT850068E PT96929129T PT96929129T PT850068E PT 850068 E PT850068 E PT 850068E PT 96929129 T PT96929129 T PT 96929129T PT 96929129 T PT96929129 T PT 96929129T PT 850068 E PT850068 E PT 850068E
Authority
PT
Portugal
Prior art keywords
pct
lipid extract
date
inflammatory activity
sec
Prior art date
Application number
PT96929129T
Other languages
English (en)
Portuguese (pt)
Inventor
Macrides Theodore
Kalafatis Nicolette
Original Assignee
Pharmalink Internat Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmalink Internat Ltd filed Critical Pharmalink Internat Ltd
Publication of PT850068E publication Critical patent/PT850068E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
PT96929129T 1995-09-11 1996-09-10 Extracto lipidico com actividade anti-inflamatoria PT850068E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN5311A AUPN531195A0 (en) 1995-09-11 1995-09-11 Lipid extract having anti-inflamatory activity

Publications (1)

Publication Number Publication Date
PT850068E true PT850068E (pt) 2005-08-31

Family

ID=3789640

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96929129T PT850068E (pt) 1995-09-11 1996-09-10 Extracto lipidico com actividade anti-inflamatoria

Country Status (12)

Country Link
US (2) US6083536A (2)
EP (1) EP0850068B1 (2)
JP (1) JP4101876B2 (2)
AT (1) ATE293984T1 (2)
AU (1) AUPN531195A0 (2)
CA (1) CA2231803C (2)
DE (1) DE69634666T2 (2)
DK (1) DK0850068T3 (2)
ES (1) ES2241001T3 (2)
PT (1) PT850068E (2)
WO (1) WO1997009992A1 (2)
ZA (1) ZA967626B (2)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN531195A0 (en) * 1995-09-11 1995-10-05 J.W. Broadbent Nominees Pty. Ltd. Lipid extract having anti-inflamatory activity
US6479277B2 (en) 1997-06-04 2002-11-12 Cellular Improvements Ltd. Method and apparatus for disruption of biological material
SE9703085D0 (sv) * 1997-08-27 1997-08-27 Micro Active Protein In Sweden Anti-microbial composition
US6946144B1 (en) 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
US7220427B2 (en) 1998-07-08 2007-05-22 Oryxe Mixture for transdermal delivery of low and high molecular weight compounds
DE19838794A1 (de) * 1998-08-26 2000-03-09 Aristavet Veterinaerspezialita Zusammensetzung zur Behandlung von Osteoarthritis und zur nutritiven Behandlung des Gelenkknorpels
AUPP910699A0 (en) * 1999-03-10 1999-04-01 Pharmalink International Limited Inhibitor of lipoxygenase pathways
US6596303B1 (en) * 1999-03-22 2003-07-22 Mars Incorporated Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals
AU2005200953B2 (en) * 1999-03-22 2007-07-12 Mars, Incorporated Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals and method of manufacturing same
US20020018787A1 (en) * 1999-05-21 2002-02-14 Roger V. Kendall Methods and compositions for modulating immune response and for the treatment of inflammatory disease
DE60038320D1 (de) * 1999-07-21 2008-04-24 Bomac Research Ltd Mittel zur bekämpfung von entzündungen und/oder degenerativen erkrankungen
DE60012026T2 (de) * 1999-08-26 2004-12-30 Ganeden Biotech, Inc., San Diego Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
AUPR030800A0 (en) 2000-09-22 2000-10-12 Pharmalink International Limited Immunomodulatory preparation
AU2001293477B2 (en) * 2000-09-22 2006-05-18 Pharmalink International Limited Immunomodulatory preparation
US7519546B2 (en) * 2001-04-30 2009-04-14 General Electric Company Maintaining synchronization of information published to multiple subscribers
EP1417211B1 (en) 2001-07-27 2007-05-30 Neptune Technologies & Bioressources Inc. Natural phospholipids of marine origin containing flavonoids and polyunsaturated phospholipids and their uses
AUPS082102A0 (en) * 2002-03-01 2002-03-21 Women's And Children's Hospital Therapeutic properties of oils
WO2003077811A1 (en) * 2002-03-14 2003-09-25 Mcclung Jackie H Pharmaceutically active compounds containing phosphorous defficient oil
DE20210182U1 (de) * 2002-07-01 2002-10-02 Bio-Innovation Development Ltd., Christchurch Wirkstoffzusammensetzung aus Bestandteilen der Grünlippenmuschel (perna canaliculus) und zusätzlichen Omega-3-Fettsäuren
EP1603405A4 (en) * 2003-03-14 2006-05-24 Foodscience Corp METHOD FOR THE TREATMENT OF CANCER WITH PERNA CANALICULUS INGREDIENTS (EN) AND PERNA CANALICULUS EXTRACTS
US7052715B2 (en) * 2003-04-11 2006-05-30 All Natural Fmg, Inc. Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
US7033998B2 (en) * 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
US7572464B2 (en) * 2004-01-30 2009-08-11 Bionovate Limited Solvent extraction of lipids such as essential fatty acids
GB0411165D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Hyaluronic acid containing pharmaceutical or veterinary compounds
GB0411166D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Treatment for asthma and arthritis
US20060039992A1 (en) * 2004-06-02 2006-02-23 Miller Bruce A Jr Novel compositions and methods utilizing green-lipped mussel and fatty acids
WO2006052150A1 (en) * 2004-11-15 2006-05-18 University Of Otago Mussel extract composition with enhanced anti-inflammatory activity
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
US8431165B2 (en) * 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
NZ563125A (en) * 2005-06-03 2009-11-27 Mcfarlane Marketing Aust Pty L Lipid extract of mussels and method for preparation thereof
NZ547429A (en) * 2006-05-24 2009-09-25 Ind Res Ltd Extraction of highly unsaturated lipids with liquid dimethyl ether
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
CA2657636C (en) 2006-07-18 2021-11-09 Techfields Biochem Co. Ltd Positively charged water soluble prodrugs of ibuprofen with very fast skin penetration rate
CN101500982A (zh) 2006-07-25 2009-08-05 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性双氯芬酸前药
PL2049482T3 (pl) 2006-08-08 2016-04-29 Techfields Biochem Co Ltd Dodatnio naładowane rozpuszczalne w wodzie proleki kwasów arylo- i heteroarylooctowych o bardzo dużej szybkości przenikania przez skórę
EP2084132B1 (en) 2006-09-03 2018-08-08 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate
JP5466006B2 (ja) 2006-09-03 2014-04-09 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
WO2008035756A1 (en) * 2006-09-22 2008-03-27 Heimat Co., Ltd. Anti-angiogenic composition comprising extract having anti-angiogenic activity and lecithin
EP2781505A1 (en) * 2006-10-02 2014-09-24 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates
CN101522692A (zh) 2006-10-11 2009-09-02 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性的昔康及其相关化合物的前药
NZ552238A (en) 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
WO2008146298A1 (en) * 2007-06-01 2008-12-04 Ganga Raju Gokaraju Use of aphanamixis polystacha extracts or fractions against 5 -lipoxygenase mediated diseases
WO2008149181A1 (en) 2007-06-04 2008-12-11 Techfields Inc Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
MX340963B (es) * 2008-04-28 2016-07-29 Vermont Italia Srl Formulacion farmaceutica que contiene palmitoil etanolamida y estearoil etanolamida.
RU2630577C2 (ru) 2008-12-04 2017-09-11 Чунси ЮЙ Композиции интенсивного проникновения и их применение
JP5313064B2 (ja) * 2009-07-03 2013-10-09 株式会社ノエビア 中性脂肪蓄積促進剤、豊胸剤
ES2969344T3 (es) 2012-01-18 2024-05-17 Techfields Pharma Co Ltd Composiciones de profármaco de alta penetración y composición farmacéutica del mismo para el tratamiento de afecciones pulmonares
SG11201505076UA (en) 2012-12-31 2015-07-30 Jrx Biotechnology Inc Liquid topical pharmaceutical nano-emulsion formulations
JP6176655B2 (ja) * 2013-07-02 2017-08-09 御木本製薬株式会社 マトリックスメタロプロテアーゼ活性阻害剤、皮膚外用剤、老化防止用皮膚外用剤、シワ防止用皮膚外用剤、慢性関節リウマチ及び他の疾患の治療又は予防剤
AU2015402832B2 (en) * 2015-07-20 2022-06-02 Jiangyin Bengt I. Samuelsson Institute Of Life Science Co., Ltd. Mussel adhesive protein product and applications thereof in suppression of skin inflammations
US11260018B2 (en) 2015-09-17 2022-03-01 Jrx Biotechnology, Inc. Approaches for improving skin hydration and moisturization
US20200016215A1 (en) * 2016-12-20 2020-01-16 Sanford Limited Bioactive mussel compositions and/or extracts
KR20200096593A (ko) * 2017-12-04 2020-08-12 림프로스트 테크놀로지스 에이에스 갑각류 어획물로부터 단백질 인지질 복합체를 제조하는 방법
WO2019123400A1 (en) 2017-12-22 2019-06-27 Pharmalink International Limited Lipid combinations
US12604918B2 (en) 2020-01-21 2026-04-21 Lintbells Limited Synergistic compositions
KR20220131272A (ko) 2020-01-21 2022-09-27 린트벨스 리미티드 상승효과가 있는 조성물
CN113041263B (zh) * 2021-03-15 2023-07-25 青岛大学 一种贻贝功能性脂质在制备治疗2型糖尿病产品中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965855D1 (en) 1978-09-25 1983-08-18 Farlane Stuart John Mc Pharmaceutical preparations containing a mollusc extract
US4801453A (en) * 1984-05-01 1989-01-31 James M. Broadbent Stabilized mussel extract
AUPM740594A0 (en) 1994-08-11 1994-09-01 J.W. Broadbent Nominees Pty. Ltd. Anti-inflammatory preparation
AU3156595A (en) * 1994-08-11 1996-03-07 J.W. Broadbent Nominees Pty. Ltd. Anti-inflammatory preparation
AUPN531195A0 (en) * 1995-09-11 1995-10-05 J.W. Broadbent Nominees Pty. Ltd. Lipid extract having anti-inflamatory activity

Also Published As

Publication number Publication date
US6083536A (en) 2000-07-04
CA2231803A1 (en) 1997-03-20
WO1997009992A1 (en) 1997-03-20
AUPN531195A0 (en) 1995-10-05
DE69634666D1 (de) 2005-06-02
US6346278B1 (en) 2002-02-12
ATE293984T1 (de) 2005-05-15
CA2231803C (en) 2004-11-23
EP0850068A1 (en) 1998-07-01
EP0850068A4 (en) 2000-09-13
DK0850068T3 (da) 2005-08-15
ES2241001T3 (es) 2005-10-16
JP4101876B2 (ja) 2008-06-18
ZA967626B (en) 1997-09-03
EP0850068B1 (en) 2005-04-27
JPH11512400A (ja) 1999-10-26
DE69634666T2 (de) 2006-04-27

Similar Documents

Publication Publication Date Title
DK0850068T3 (da) Lipidekstrakt med antiinflammatorisk aktivitet
DE69940975D1 (de) Verwendung von glp-1 oder analoge zur behandlung von schlaganfall
DK0880350T3 (da) Behandling af dissemineret sklerose
FI970101A0 (fi) Uusi farmaseuttinen valmiste kivun hallintaan
DK0731699T3 (da) Fremgangsmåde til reduktion af legemsfedt i dyr ved indgivelse af konjugeret linolsyre
PT920323E (pt) Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica
DE69814394D1 (de) Verwendung von levobupivacain
FI970747A0 (fi) Yhdistelmävalmiste käytettäväksi immunologisissa sairauksissa
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
ATE263571T1 (de) Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen
ATE79761T1 (de) Behandlung einer krankheit vom aids-typ.
RU95103436A (ru) Способ замедления прогрессирования атеросклероза коронарных артерий с помощью правастатина
AU3092397A (en) Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases
NO971182L (no) Anvendelse av 2,4-diaminopyrimidin-3-oksyd eller et salt derav for behandling av maturasjons- og struktureringsforstyrrelser av kollagen
AU3401093A (en) Therapeutic agent for threatened abortion
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
ES2110104T3 (es) Procedimiento para la administracion de soluciones de factor de estimulacion de las colonias de granulocitos.
IL110888A0 (en) Pharmaceutical compositions for the treatment of liver diseases comprising a benzothiazepine derivative
Bellman AIDS practice issues today: interview with Paul Bellman, MD Interview by John S. James
ES2181160T3 (es) Derivados de 1,4-dihidropiridina y su utilizacion en terapia.
ECSP951424A (es) Procedimiento para la administracion de azitromicina
UA22223A (uk) Спосіб лікуваhhя захворюваhь оргаhа зору